Clinical Characteristics of Children with Cerebral Injury preceding Treatment of Diabetic Ketoacidosis

Nicole S Glaser1, Kimberly S Quayle2, Julie K McManemy3

  • 1Department of Pediatrics, University of California Davis Health, University of California Davis School of Medicine, CA.

Insights

Lower pH and higher blood urea nitrogen (BUN) indicate a risk of cerebral injury in children with diabetic ketoacidosis (DKA) even before treatment begins. These factors are key indicators of potential brain complications in pediatric DKA cases.

Area of Science:

  • Pediatric Endocrinology
  • Neurology
  • Metabolic Disorders

Background:

  • Diabetic ketoacidosis (DKA) is a serious complication of diabetes in children.
  • Cerebral injury is a known risk during DKA treatment, linked to acidosis and high blood urea nitrogen (BUN).
  • The timing and predictors of cerebral injury relative to DKA onset and treatment require further investigation.

Observation:

  • This study examined the association between presenting clinical parameters and cerebral injury in pediatric DKA.
  • Cerebral injury can manifest at the time of diagnosis, prior to initiating DKA management.
  • Key biochemical markers at presentation were analyzed for their correlation with neurological complications.

Findings:

  • Lower pH levels at presentation were significantly associated with cerebral injury in children with DKA.
  • Elevated blood urea nitrogen (BUN) levels upon admission also correlated with an increased risk of cerebral injury.
  • These findings suggest that metabolic derangements at the initial presentation are critical indicators.

Implications:

  • Identifying high-risk patients at presentation allows for targeted monitoring and potentially earlier intervention.
  • Understanding pre-treatment risk factors can guide management strategies to mitigate neurological damage.
  • Further research into the mechanisms linking acidosis, BUN, and cerebral injury in pediatric DKA is warranted.

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
668
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.0K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.7K
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
74
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
234